Clinical Trial Update: DMT210 Topical Gel in the Treatment of Acne Rosacea [Phase 2]

View source ↗

Summary

Dermata Therapeutics confirms completion of the Phase 2 trial of DMT210 topical gel for acne rosacea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• DMT210 Topical Gel

Snippet

Sponsor: Dermata Therapeutics | Conditions: Acne Rosacea | Phase 2 | Status: COMPLETED